{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:42:12Z","timestamp":1791049332700,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:p>\n            Specific treatment of age-related aortic wall arteriosclerosis and stiffening is lacking. Because ligands for peroxisome proliferator-activated receptor \u03b3 have beneficial effects on the arterial wall in atherosclerosis, via an antiinflammatory mechanism, we investigated whether long-term pioglitazone (Pio) treatment protects against another form of vascular wall disease, arteriosclerosis. We evaluated, in a rat model of elastocalcinotic arteriosclerosis (hypervitaminosis D and nicotine [VDN]), whether Pio (3 mg \u00b7 kg\n            <jats:sup>\u22121<\/jats:sup>\n            per day for 1.5 month PO) attenuated arteriosclerosis and its consequences: aortic wall rigidity, increased aortic pulse pressure, and left ventricular hypertrophy. In VDN rats, medial calcification was associated with monocyte\/macrophage infiltration and induction of tumor necrosis factor \u03b1 and interleukin 1\u03b2. Pio increased nuclear peroxisome proliferator-activated receptor \u03b3 immunostaining in the aortic wall, decreased tumor necrosis factor \u03b1 (\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05 versus VDN Pio\n            <jats:sup>\u2212<\/jats:sup>\n            ), tended to decrease interleukin 1\u03b2 mRNA expression (\n            <jats:italic>P<\/jats:italic>\n            =0.08 versus VDN Pio\n            <jats:sup>\u2212<\/jats:sup>\n            ), blunted aortic wall calcification (271\u00b169,\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05 versus VDN Pio\n            <jats:sup>\u2212<\/jats:sup>\n            562\u00b187 \u03bcmol \u00b7 g\n            <jats:sup>\u22121<\/jats:sup>\n            dry weight) and prevented fragmentation of elastic fibers (segments per 10 000 \u03bcm\n            <jats:sup>2<\/jats:sup>\n            : 8.4\u00b10.3;\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05 versus VDN Pio\n            <jats:sup>\u2212<\/jats:sup>\n            10.5\u00b10.6). Pio reduced aortic wall stiffness (elastic modulus\/wall stress: 4.8\u00b10.6;\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05 versus VDN Pio\n            <jats:sup>\u2212<\/jats:sup>\n            10.0\u00b11.6), aortic pulse pressure (30\u00b12 mm Hg;\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05 versus VDN Pio\n            <jats:sup>\u2212<\/jats:sup>\n            39\u00b14) and left ventricular hypertrophy (1.58\u00b10.05 g \u00b7 kg\n            <jats:sup>\u22121<\/jats:sup>\n            ;\n            <jats:italic>P<\/jats:italic>\n            &lt;0.05 versus VDN Pio\n            <jats:sup>\u2212<\/jats:sup>\n            1.76\u00b10.06). In conclusion, long-term Pio treatment attenuates aortic wall elastocalcinosis and, thus, lowers aortic wall stiffness, aortic pulse pressure, and left ventricular hypertrophy.\n          <\/jats:p>","DOI":"10.1161\/01.hyp.0000171472.24422.33","type":"journal-article","created":{"date-parts":[[2005,6,21]],"date-time":"2005-06-21T00:28:35Z","timestamp":1119313715000},"page":"372-379","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":45,"title":["Pioglitazone Improves Aortic Wall Elasticity in a Rat Model of Elastocalcinotic Arteriosclerosis"],"prefix":"10.1161","volume":"46","author":[{"given":"Virginie","family":"Gaillard","sequence":"first","affiliation":[{"name":"From the Unite\u0301 Mixte UHP-INSERM U684, Pharmacology Laboratory Faculte\u0301 de Pharmacie (V.G., J.A., I.L.), and Faculte\u0301 de Me\u0301decine (C.S.-D.), Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy; Groupe Rein et Hypertension (EA3127) (D.C.), Institut Universitaire de Recherche Clinique, Montpellier; Peroxisome Proliferators (EA 3446) (H.S., M.D.), Faculte\u0301 des Sciences et Techniques, Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Casellas","sequence":"additional","affiliation":[{"name":"From the Unite\u0301 Mixte UHP-INSERM U684, Pharmacology Laboratory Faculte\u0301 de Pharmacie (V.G., J.A., I.L.), and Faculte\u0301 de Me\u0301decine (C.S.-D.), Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy; Groupe Rein et Hypertension (EA3127) (D.C.), Institut Universitaire de Recherche Clinique, Montpellier; Peroxisome Proliferators (EA 3446) (H.S., M.D.), Faculte\u0301 des Sciences et Techniques, Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Seguin-Devaux","sequence":"additional","affiliation":[{"name":"From the Unite\u0301 Mixte UHP-INSERM U684, Pharmacology Laboratory Faculte\u0301 de Pharmacie (V.G., J.A., I.L.), and Faculte\u0301 de Me\u0301decine (C.S.-D.), Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy; Groupe Rein et Hypertension (EA3127) (D.C.), Institut Universitaire de Recherche Clinique, Montpellier; Peroxisome Proliferators (EA 3446) (H.S., M.D.), Faculte\u0301 des Sciences et Techniques, Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herve\u0301","family":"Schohn","sequence":"additional","affiliation":[{"name":"From the Unite\u0301 Mixte UHP-INSERM U684, Pharmacology Laboratory Faculte\u0301 de Pharmacie (V.G., J.A., I.L.), and Faculte\u0301 de Me\u0301decine (C.S.-D.), Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy; Groupe Rein et Hypertension (EA3127) (D.C.), Institut Universitaire de Recherche Clinique, Montpellier; Peroxisome Proliferators (EA 3446) (H.S., M.D.), Faculte\u0301 des Sciences et Techniques, Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Dauc\u0327a","sequence":"additional","affiliation":[{"name":"From the Unite\u0301 Mixte UHP-INSERM U684, Pharmacology Laboratory Faculte\u0301 de Pharmacie (V.G., J.A., I.L.), and Faculte\u0301 de Me\u0301decine (C.S.-D.), Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy; Groupe Rein et Hypertension (EA3127) (D.C.), Institut Universitaire de Recherche Clinique, Montpellier; Peroxisome Proliferators (EA 3446) (H.S., M.D.), Faculte\u0301 des Sciences et Techniques, Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Atkinson","sequence":"additional","affiliation":[{"name":"From the Unite\u0301 Mixte UHP-INSERM U684, Pharmacology Laboratory Faculte\u0301 de Pharmacie (V.G., J.A., I.L.), and Faculte\u0301 de Me\u0301decine (C.S.-D.), Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy; Groupe Rein et Hypertension (EA3127) (D.C.), Institut Universitaire de Recherche Clinique, Montpellier; Peroxisome Proliferators (EA 3446) (H.S., M.D.), Faculte\u0301 des Sciences et Techniques, Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lartaud","sequence":"additional","affiliation":[{"name":"From the Unite\u0301 Mixte UHP-INSERM U684, Pharmacology Laboratory Faculte\u0301 de Pharmacie (V.G., J.A., I.L.), and Faculte\u0301 de Me\u0301decine (C.S.-D.), Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy; Groupe Rein et Hypertension (EA3127) (D.C.), Institut Universitaire de Recherche Clinique, Montpellier; Peroxisome Proliferators (EA 3446) (H.S., M.D.), Faculte\u0301 des Sciences et Techniques, Universite\u0301 Henri Poincare\u0301 Nancy-1, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.32.3.565"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.33.5.1111"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.21.12.2046"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","unstructured":"Fleckenstein A Frey M Fleckenstein-Grun G. Protection by calcium antagonists against experimental arterial calcinosis. Secondary Prevention of Coronary Heart Disease Workshop of the International Society and Federation of Cardiology. New York: Py\u00f6r\u00e4l\u00e4 K Georg Thieme Verlag; 1983: 109\u2013122.","DOI":"10.1007\/978-94-009-5024-5_13"},{"key":"e_1_3_2_5_2","first-page":"677","volume":"47","year":"1999","unstructured":"Atkinson J. Arterial calcification. Mechanisms, consequences and animal models. Pathol Biol. 1999; 47: 677\u2013684.","journal-title":"Pathol Biol"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.38.4.943"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.104.13.1464"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4914(02)02385-7"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.101.11.1311"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000036396.64769.c2"},{"key":"e_1_3_2_11_2","first-page":"919","volume":"9","year":"1991","unstructured":"Henrion D, Chillon JM, Godeau G, Muller F, Capdeville-Atkinson C, Hoffman M, Atkinson J. The consequences of aortic calcium overload following vitamin D3 plus nicotine treatment in young rats. J Hypertens. 1991; 9: 919\u2013926.","journal-title":"J Hypertens"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000159247"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.34.1.63"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.30.5.1169"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/atvb.21.7.1184"},{"key":"e_1_3_2_16_2","first-page":"163","volume":"29","year":"1901","unstructured":"Von Kossa J. Uber die im organismus k\u00fcnstlich erzeugboren Verkalkungen. Beitr Path Anat. 1901; 29: 163\u2013202.","journal-title":"Beitr Path Anat"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.2000.279.4.C1045"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00008.2002"},{"key":"e_1_3_2_19_2","first-page":"1110","volume":"5","year":"1963","unstructured":"Ghuysen JM, Strominger JL. Structure of the cell wall of Staphylococcus aureus, strain Copenhagen. I. Preparation of fragments by enzymatic hydrolysis. Biochemistry. 1963; 5: 1110\u20131119.","journal-title":"Biochemistry"},{"key":"e_1_3_2_20_2","first-page":"549","volume":"184","year":"1950","unstructured":"Neuman RE, Logan MA. The determination of collagen and elastin in tissues. J Biol Chem. 1950; 184: 549\u2013556.","journal-title":"J Biol Chem"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.0832"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/002215540004800504"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/34178"},{"key":"e_1_3_2_24_2","first-page":"205","volume":"62","year":"1998","unstructured":"Hida Y, Kawada T, Kayahashi S, Ishihara T, Fushiki T. Counteraction of retinoic acid and 1,25-dihydroxyvitamin D3 on up-regulation of adipocyte differentiation with PPARgamma ligand, an antidiabetic thiazolidinedione, in 3T3\u2013L1 cells. Life Sci. 1998; 62: 205\u2013211.","journal-title":"Life Sci"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00567-1"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000033987.22436.50"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.11.7116"},{"key":"e_1_3_2_28_2","first-page":"395","volume":"34","year":"1958","unstructured":"Hass GM, Trueheart RE, Taylor CB, Stumpe M. An experimental histologic study of hypervitaminosis D. Am J Pathol. 1958; 34: 395\u2013431.","journal-title":"Am J Pathol"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701669"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.83.11.1097"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10370"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(07)70083-6"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.13.3.215"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.27.4.949"},{"key":"e_1_3_2_35_2","first-page":"1","volume":"260","year":"1992","unstructured":"Henrion D, Chillon JM, Capdeville-Atkinson C, Atkinson J. Effect of long-term treatment with the calcium entry blocker, isradipine, on vascular calcium overload produced by vitamin D3 and nicotine in rats. J Pharmacol Exp Ther. 1992; 260: 1\u20138.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.0000171472.24422.33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:10:04Z","timestamp":1715530204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.0000171472.24422.33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1161\/01.HYP.0000171472.24422.33"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.0000171472.24422.33","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"2004-10-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-05-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-06-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}